Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Takakura

Showing results (71-80 of 241) with videos related to

Pageof 25
Sort By:
The American Journal of Physiology|May 1, 1995
Galactosylated proteins are recognized by the liver according to the surface density of galactose moietiesM Nishikawa, C Miyazaki, F Yamashita, et al.
Journal of Microscopy|February 24, 2005
Waveguide sidewall roughness measurement on full wafers by SEM-based stereoscopyA Bony, A Heid, Y Takakura, et al.
Pharmaceutical Research|April 1, 1997
Non-polarized secretion of mouse interferon-beta from gene-transferred human intestinal Caco-2 cellsK Kawabata, M Kondo, Y Watanabe, et al.
Journal of Pharmaceutical Sciences|June 1, 1997
Effects of skin metabolism on percutaneous penetration of lipophilic drugsH Bando, S Mohri, F Yamashita, et al.
Journal of Drug Targeting|January 1, 1993
Controlled biodistribution of highly lipophilic drugs with various parenteral formulationsT Takino, C Nakajima, Y Takakura, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 17, 2014
An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancerY Takakura, S Ikeda, Y Imaoka, et al.
Cancer Research|March 1, 1990
Disposition of anticancer drugs after bolus arterial administration in a tissue-isolated tumor perfusion systemK Ohkouchi, H Imoto, Y Takakura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 1999
Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targetingM Hashida, K Akamatsu, M Nishikawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
Development of a hepatocyte-specific prostaglandin E(1) polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in miceK Akamatsu, Y Yamasaki, M Nishikawa, et al.
Biological & Pharmaceutical Bulletin|January 9, 1999
Hepatic disposition characteristics of recombinant human interleukin-11 (rhIL-11) in the perfused rat liverA Takagi, Y Yabe, M Yoshida, et al.
Pageof 25

Showing results (71-80 of 241) with videos related to

Sort By:
Pageof 25
The American Journal of Physiology|May 1, 1995
Galactosylated proteins are recognized by the liver according to the surface density of galactose moietiesM Nishikawa, C Miyazaki, F Yamashita, et al.
Journal of Microscopy|February 24, 2005
Waveguide sidewall roughness measurement on full wafers by SEM-based stereoscopyA Bony, A Heid, Y Takakura, et al.
Pharmaceutical Research|April 1, 1997
Non-polarized secretion of mouse interferon-beta from gene-transferred human intestinal Caco-2 cellsK Kawabata, M Kondo, Y Watanabe, et al.
Journal of Pharmaceutical Sciences|June 1, 1997
Effects of skin metabolism on percutaneous penetration of lipophilic drugsH Bando, S Mohri, F Yamashita, et al.
Journal of Drug Targeting|January 1, 1993
Controlled biodistribution of highly lipophilic drugs with various parenteral formulationsT Takino, C Nakajima, Y Takakura, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 17, 2014
An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancerY Takakura, S Ikeda, Y Imaoka, et al.
Cancer Research|March 1, 1990
Disposition of anticancer drugs after bolus arterial administration in a tissue-isolated tumor perfusion systemK Ohkouchi, H Imoto, Y Takakura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 1999
Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targetingM Hashida, K Akamatsu, M Nishikawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
Development of a hepatocyte-specific prostaglandin E(1) polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in miceK Akamatsu, Y Yamasaki, M Nishikawa, et al.
Biological & Pharmaceutical Bulletin|January 9, 1999
Hepatic disposition characteristics of recombinant human interleukin-11 (rhIL-11) in the perfused rat liverA Takagi, Y Yabe, M Yoshida, et al.
Pageof 25